AlphaSense gives 3T a "one-stop-shop" to accelerate their research

3T Biosciences, a smaller TCR-based immunotherapy biotech, faced resource constraints gaining competitive insight across diverse research materials. It adopted AlphaSense as a cost-effective, consolidated platform in place of multiple database subscriptions, giving its Chief Business Officer streamlined access to sources like Endpoints News and the San Francisco Business Times in one interface for efficient competitive analysis without a dedicated CI team. The page states no specific quantitative outcome, and notes 3T plans to further explore AlphaSense's generative AI capabilities to expand its intelligence operations.

AlphaSense is an AI-powered search platform over premium business documents, earnings calls, filings and expert-network transcripts, used by pharma competitive-intelligence and business-development teams.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.